Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 736NIH 144INDUSTRY 129NETWORK 106OTHER_GOV 5UNKNOWN 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 2Leukemia 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Pemetrexed 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Cytarabine × Clear all
NCT01191541 2021-08-10

Ara-C

ChineseAMS

Phase 4 Completed
65 enrolled 8 charts
Other hematologic neoplasm

Leukemia

NCT02432872 2016-10-07

Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years

ChineseAMS

Phase NA Unknown
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02432911 2016-10-07

Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old

ChineseAMS

Phase NA Unknown
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡